BACC
NASDAQ · N/A
Blue Acquisition Corp-Cl A
$10.48
+0.01 (+0.10%)
Open$10.48
Previous Close$10.47
Day High$10.49
Day Low$10.46
52W High$11.10
52W Low$10.09
Volume—
Avg Volume152.7K
Market Cap293.60M
P/E Ratio66.69
EPS$0.34
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.44M | 9.19M | 8.42M |
| Net Income | 1.68M | 1.36M | 1.44M |
| Profit Margin | 17.8% | 14.8% | 17.1% |
| EBITDA | 1.98M | 2.08M | 2.05M |
| Free Cash Flow | 765.5K | 667.4K | 663.8K |
| Rev Growth | -5.7% | -2.9% | -3.8% |
| Debt/Equity | 0.62 | 0.61 | 0.65 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.71 | -4.32% | — | 585.99M |
| PICS | Pics Nv | $5.01 | -1.96% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.27 | +0.39% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.63 | +0.05% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.34 | +0.05% | 41.5 | 590.36M |